Deubiquitinating enzyme (DUB) plays a pivotal role in maintaining the balance of intracellular protein ubiquitination levels and in modulating the initiation and progression of colorectal cancer (CRC) through diverse metabolic pathways, making it a promising target in colorectal cancer treatment strategies